The aggressive phenotype of RA synovial fibroblasts (RASF) is characterised by the increased expression of matrix metalloproteinase (MMP)-1 as well as the small ubiquitin like modifier (SUMO)-1 and decreased expression of SUMO-specific protease SENP1. Since we showed an increased activity of acetyltransferases in this autoimmune disease, we wanted to analyse whether this affects the expression of MMP-1 and can be reversed by the reconstitution of SENP1.
Epigenetics and Rheumatoid

Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterised by persistent inflammatory processes in the joints resulting in a progressive articular destruction associated with the loss of joint function and disability (1, 2) . RA synovial fibroblasts (RASF) are intrinsically activated and therefore invade into cartilage by excessive expression of matrix degrading enzymes such as matrix metalloproteinases (MMPs) MMP-1, 3, 9, 10 and 13 (3) (4) (5) (6) (7) .
MMP-1 is one of the most important MMPs since it is responsible for cartilage destruction by cleaving collagen type II.
Recently, our group could show that in RA synovial tissues the balance of activity of histone acetyltransferases (HATs) and histone deacetylases (HDACs) is strongly shifted towards histone acetylation (8) , which is associated with increased transcription rates (9, 10) . This posttranslational modification of histones belongs to epigenetic modifications regulating gene expression and offers us new mechanism for therapeutic strategies. Another posttranslational modification described in RA is SUMOylation (11, 12) . We could show that RASF have intrinsically high levels of small ubiquitin like modifier (SUMO) -1 paralleled by decreased levels of its specific protease (SENP1) which renders them apoptosis-resistant.
Whereas posttranslational modifications such as acetylation/deacetylation directly influence gene transcription, SUMO-1 can influence the properties of its substrates such as stability, localization, interaction with other proteins and activity (13) (14) (15) . Histone deacetylase 4 (HDAC 4) is known to be modified by SUMO-1 and this is thought to modulate its activity as a negative regulator of transcription (16) . There is, however, uncertainty regarding the influence of SUMOylation on the activity of HDAC4. Kirsh et al. reported that a SUMOylation-deficient mutant of HDAC4 shows only a slightly impaired ability to repress the transcription while the nuclear transport of HDAC4 results from the modification by SUMO-1 (16) . This suggests that sumoylation of HDAC4 could rather contribute to the change in the localization of HDAC4 than influence the activity directly.
Since SUMO-1 is a modifier of a wide range of transcription and epigenetic factors, we studied here to which extent the activated phenotype of RASF characterised by excessive production of MMP-1 can be modified by epigenetic changes driven by desumoylation. This is the first study linking SUMOylation and the production of MMP-1 to an epigenetic control mechanism mediated through histone acetylation, and therefore, it supports the idea that epigenetic modulations are involved in RA (17) .
Materials and Methods
Cells and patients
Synovial fibroblasts were obtained from RA (n=8) and OA patients (n=3) undergoing joint replacement surgery and grown in DMEM with 10% FCS until passages 4-6 as described (18) . All RA patients fulfilled the American College of Rheumatology criteria for RA (19) .
Expression vectors, siRNA, and transfection
A GFP-tagged SENP1 expression vector (SENP1-pEGF-C1) was generated by subcloning SENP1 into pEGF-C1 as described previously (12) . HDAC4 siGENOME SMARTpool was purchased from Dharmacon, Lausanne, Switzerland and siRNA HDAC4 from Santa Cruz, Heidelberg, Germany. The mock vector pEGF-C1 or mismatch oligonucleotides (Qiagen, Hombrechtikon, Switzerland) were used as controls. Transfection of the cells with SENP1 and HDAC4 siRNA were performed by AMAXA nucleofection as described previously (20) .
Chromatin immunoprecipitation
In a typical experiment, 0.5 million of SF were harvested, chromatin was crosslinked with 1% formaldehyde for 10 min and the reaction was quenched by adding glycine. Cells were washed twice, snap frozen and stored at -80°C or immediately used. Chromatin sonication was performed on ice in SDS lysis buffer containing protease inhibitors (1x protease inhibitors cocktail, Roche, Basel, Switzerland), 5mM sodium butyrate (Sigma, Buchs SG, Switzerland) and 2.5 μM TSA (Sigma) using Bandelin sonopuls UW 2070 sonicator and a program of 4 cycles of 10s at 57% power. The efficiency of the sonication of the chromatin was analysed by gel electophoresis. 10% of the sample were kept as input. Chromatin was diluted in ChIP dilution buffer and pre-cleaned by incubation with normal rabbit serum and pre-blocked Protein A agarose beads (Upstate/Millipore, Zug, Switzerland) for at least 2 h.
Chromatin immunoprecipitation was performed by overnight incubation with anti-acetyl H4 antibodies, rabbit anti-HDAC4 antibodies (Santa Cruz) or isotype IgG as a negative control and followed by at least 4 h incubation with Protein A agarose beads. Subsequently, immunoprecipitates were washed with buffers containing protease inhibitors and sodium butyrate and incubated for 20 min with the elution buffer containing proteinase K. Reverse crosslinking was performed overnight at 64°C and the DNA was purified using the QIAquick gel extraction kit (Qiagen).
RNA extraction
Total RNA was isolated and converted into cDNA and gene expression was quantified by Real-time PCR as described (20, 21) .
Real-time polymerase chain reaction
Quantification of mRNA Expression of MMP-1 was assessed using self designed previously published primers and probe (22) and HDAC4 mRNA was quantified by Real-time PCR using SybrGreen primers: 
Flow cytometry analysis (FACS)
Cells were permeabilised with 0.4% triton X-100 and incubated with rabbit anti-acetyl H4 (Upstate/Millipore) antibodies and followed by incubation with R-Phycoerythrin-labeled donkey anti-rabbit antibodies (Jackson ImmunoResearch). Unbound antibodies were removed by two washing steps. In control experiments primary antibodies were replaced by a mouse IgG isotype in the same concentration. Measurements were performed using 10.000 cells per sample at ''low-flow'' modus using FACSCalibur (BD Biosciences, Allschwil Switzerland).
Acid extraction of histones
Following transfection, cells were splited into two portions and the first portion was subjected to acid extraction of histones, while second portion was lysed in Lemmli buffer and used to assess the efficiency of the transfection. The acid extraction was performed as previously described (23) . Briefly, nuclear extracts were prepared by cell lysis in cold hypotonic lysis buffer (10mM Tris -Cl pH 8.0, 1mM KCl, 1.5 mM MgCl 2 , 1mM DTT, 1mM PMSF, containing 1x protease inhibitors cocktail (Roche), 1.25 mg/ml sodium butyrate (Sigma) and 2μM trichostatin A (Sigma)). The nuclei were resuspended nuclei in 0.4N H 2 SO 4 and incubated on a rotator at 4°C for 1h. Next, histones were precipitated overnight by 33% trichloroacetic acid. The histone pellet was washed with ice-cold acetone and resuspended in distilled water.
Western blot
Following transfection, lysates were suspended in 2x concentrated Lemmli buffer (100 mM Tris HCl [pH 6.8], 40% glycerol, 10% sodium dodecyl sulfate [SDS], 0.7M β-mercaptoethanol, and 0.0005% bromphenol blue) and separated by SDS-PAGE under reducing conditions and transferred to nitrocellulose membranes as previously described (18) .
Membranes were blocked with 5% milk for 1 h at RT and then incubated overnight with rabbit anti-acetylated histone H4 (Upstate/Millipore), rabbit anti-SENP1 (Chemicon, Asperg, Germany) or mouse anti-MMP-1 (R&D Systems). As secondary reagents, HRP-conjugated goat anti-rabbit antibodies (Jackson ImmunoResearch) or HRP-conjugated rabbit anti-mouse IgG antibodies (DAKO, Baar, Switzerland) were used, and signals were visualized with an enhanced chemiluminescence system (Amersham Biosciences, Otelfingen, Switzerland). For normalization, membranes were stripped and probed with mouse anti-human α-tubulin (Sigma), mouse anti-paxillin antibodies (Neomarkers, Basel, Switzerland) or rabbit antihistone H4 (Upstate/Millipore). Evaluation of the expression of specific proteins was performed using the Alpha imager Software system (Alpha Innotech, San Leandro, CA) via pixel quantification of the electronic image.
Cell invasion assay
Investigation of synovial fibroblast invasion in vitro was performed using the recently established matrix associated transepithelial resistance invasion (MATRIN) assay as described (24) . This is a highly sensitive electrophysiological technique that is based on the 
Statistical analysis
All data are expressed as mean ± SEM. Mann-Whitney U-test was used for comparison between two groups of data. P values lower or equal to 5% were considered statistically significant (p ≤ 0.05).
Results
RASF have higher intrinsic levels of acetylated histone H4 in the promoter of MMP-1 than OASF
Since we could show that the acetylation of histones is increased in RA (8) 
Desumoylation decreases the global levels of acetylated histone H4
Since SENP1 overexpression decreased the acetylation level in the promoter of MMP-1 we were interested whether the decrease in acetylation of histones is also a global phenomenon.
Thus, we compared the global levels of acetylated histone H4 in the cells transfected with SENP1-pEGF-C1 or the mock vector. As visualized by immunofluorescence, RASF transfected with SENP1-pEGF-C1 revealed lower global levels of acetylated histone H4 when compared both to nontransfected or GFP transfected cells (n = 3, Fig. 2A) . Using flow cytometry analysis we could further confirm that the global levels of H4-acetylation were significantly decreased by 73 ± SEM 11% when compared to pEGF-C1 cells (n = 3, p < 0.05, Fig. 2B ). In addition, using Western blot we could confirm that the 3-fold overexpression of SENP1 (Fig. 2C) leads to a decrease in acetylation of histone H4 (by 51 ± SEM 4%, Fig. 2D ).
Overexpression of SENP1 results in a downregulation of MMP-1 in RASF
After we observed decreased acetylation of histones in the MMP-1 promoter in RASF overexpressing SENP1, we wanted to analyse whether it resulted in a repression of MMP-1 transcription. Indeed, the overexpression of SENP1 downregulated the expression of MMP-1 mRNA by (mean  SEM) 58  7% (n = 5, p  0.05, Fig. 3A) . Furthermore, the protein levels of MMP-1 were significantly decreased by 28 ± 6% (n = 3, p ≤ 0.05) in RASF overexpressing SENP1 compared to mock transfected cells (Fig. 3B) .
Overexpression of SENP1 in RASF results in a functionally reduced invasiveness
Next, since we observed that the overexpression of SENP1 downregulated the expression of MMP-1 in RASF, we wanted to investigate whether therefore also the invasiveness of these cells decreased. Indeed, using an in vitro functional invasion assay, we could observe that RASF transfected with SENP1 for 23h were significantly less invasive (2 ± 2 % decrease in TEER) compared to the mock transfected cells (34 ± 9% decrease in TEER, p ≤ 0.05, Fig. 3C and D). At the earlier time points (12 and 19 h after transfection) we could not observe a significant difference in the invasiveness of SENP1 overexpressing RASF compared to the control cells (Fig. 3D ). In conclusion, we could show that the overexpression of SENP1 in RASF not only alters the expression of MMP-1 but also functionally interferes with the invasive phenotype of RASF.
Overexpression of SENP1 leads to an accumulation of histone deacetylase HDAC4 on the MMP-1 promoter
Since SENP1 overexpression results in a decrease in acetylation of histones at the MMP-1 promoter, we were interested whether this is due to the counterplaying histone deacetylases.
Since HDAC4 is a substrate for sumoylation and this modification is connected with a change of localization of HDAC4, we hypothesised that the overexpression of SENP1 could mediate histone deacetylation through localizing HDAC4 to specific regions of chromatin. To investigate whether this is the case, we performed chromatin immunoprecipitation using anti- It has been described by Huber et al that in RA synovial tissues the balance of HAT/HDAC activity is strongly shifted towards histone acetylation (8) . In addition, it has been shown that several HDAC inhibitors had rather beneficial effects in the animal models, where they were shown to improve joint swelling, synovial inflammation, bone and cartilage destruction, downregulated the production of VEGF, blocked angiogenesis and promoted cell cycle arrest and apoptosis (25) (26) (27) (28) . These reports suggest that HDACs could be misplaced in the subcellular compartments for example being localized aberrantly to specific promoter sites, and thereby contribute further to the pathogenesis of RA. Therefore, it should be carefully considered whether inhibition of HDACs or rather their redirection to a proper localization is more feasible for the treatment of RA.
RASF play a crucial role in cartilage destruction by active invasion via producing MMPs (6).
Therefore, targeting of the intrinsically activated RASF could lead to the development of new therapeutic strategies for RA. We could previously show that RASF are characterised by high expression levels of SUMO-1 and at the same time low levels of SENP1 (12) . Here we demonstrate that reversing this balance by overexpression of SENP1 leads to a decrease in the invasiveness of RASF and downregulates the expression of MMP-1. Most interestingly, this regulation is dependent on a transcription inhibitor, HDAC4, since in cells silenced for HDAC4 the overexpression of SENP1 failed to decrease the expression of MMP-1.
Furthermore, we could show that upon the overexpression of SENP1 in RASF, HDAC4, localized especially to the distal region of the MMP-1 promoter. HDAC4 has been shown to be modulated by SUMO-1 by a SUMO ligase RanBP2 in the nuclear pore complex (16) . This suggests that sumoylation of HDAC4 promotes nuclear transport of the modified protein.
Such a mechanism has been shown for nuclear translocation of the insulin gene regulator Pdx1 as well as the tumor suppressor Smad4 (29) (30) (31) . We show here that SENP1 overexpression in the nucleus of RASF led further to the specific accumulation of HDAC4 on the DNA. Furthermore, SENP1 driven modulation of HDAC4 localization re-established the acetylation pattern in the MMP-1 promoter in RASF by deacetylation of histones in the distal fragment of the MMP-1 promoter. This promoter region contains predicted binding sites for acetyltransferases such as C/EBPα and p300. Moreover, this promoter region contains a predicted binding site for IRF-3, which was described to be superactivated in RA synovial tissues (32) , to be regulated by HDAC inhibitors (33) and to interact with PIASy, a SUMO ligase (34) . It needs to be investigated whether IRF-3 regulates the transcription of MMP-1.
On the contrary, no significant changes were observed in both acetylation of histones and 
